Zepp Health Corporation
NYSE:ZEPPConsumer Electronics
-$0.03 today
- Market cap
- $50.84M
- Beta
- 1.78
- P/E (TTM)
- -0.1
- EPS (TTM)
- -$282.07
Volume 0.04M
Average 0.13M
Returns on capital
Zepp Health Corporation management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-18.7%
avg 0.6%
ROIC
-6.6%
avg 2.3%
ROA
-7.1%
avg 0.2%
Analysis
ROIC is currently the strongest return metric at -6.6% versus its period average of 2.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Leon Cheng Deng | Chief Financial Officer | — | 43 | — | — |
Pengtao Yu | Chief Industrial Designer | — | 44 | 98.49K | 0.69% |
Wang Huang | Founder, Chairman & Chief Executive Officer | — | 47 | 60.08K | 0.42% |
Grace Yujia Zhang | Director of Investor Relations | — | — | — | — |
Ramesh Jain | Chief Technical Advisor of Huami AI Research Institute | — | — | — | — |
Mike Yan Yeung | Chief Operating Officer & Director | — | 55 | 100.91K | 0.70% |
Meihui Fan | Chief Technology Officer & Director | — | 47 | 0 | <0.01% |
Xiaojun Zhang | Vice President of Human Resources | — | 54 | — | — |
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 24, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
3
$87,454.12
Net Transaction Value
−$87,454.12
Net selling
Most Active
Yu Pengtao
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Sep 24, 26Sep 24, 2026 | Yu Pengtao Direct | Sell | $17.4K$17,386.59 |
| Sep 23, 26Sep 23, 2026 | Yu Pengtao Direct | Sell | $24.7K$24,723.57 |
| Jun 26, 26Jun 26, 2026 | Deng Cheng Direct | Sell | $45.3K$45,343.96 |
Summary
Insiders reported 0 buys worth $0.00 and 3 sells worth $87,454.12 over the last 12 months. That adds up to net selling of $87,454.12. Yu Pengtao was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A0 analysts |
| Revenue | N/A | N/A | -24.5% | +14.2% (3yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A — |
Analysis
Recent growth has been strongest in Revenue at -24.5% over three years. Forward estimates point to Revenue at +14.2% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Zepp Health Corporation compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about ZEPP's management, answered from reported figures.
Who manages ZEPP?
Zepp Health Corporation (ZEPP) lists 8 active executives. The top listed executive is Leon Cheng Deng, Chief Financial Officer.
Are ZEPP insiders buying or selling?
Recent insider activity shows net selling of $87,454.12.
Continue the stock analysis
Jump to another research area for this company.